Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
PGY-2 Residency in Hematology/Oncology Pharmacy Practice
Stanford Health Care (SHC) is world-renowned for advanced patient care, particularly for the treatment of cancer. It is recognized by U.S. News & World Report as one of "America's Best Hospitals" and currently ranked #129 in the U.S on the Best Hospital Honor Roll, and we are also a National Cancer Institute (NCI) Designated Cancer Center. Stanford Health Care has a close relationship with both the Stanford University School of Medicine and Lucile Packard Children's Hospital, an adjacent pediatric teaching hospital providing general acute and tertiary care. The hospitals are located on three different sites, the Stanford University campus in Palo Alto, California; it is about 20 miles north of San Jose and about 40 miles south of San Francisco, Redwood City, and San Jose (South Bay).
Clinical pharmacists at Stanford Health Care cover all acute patient care areas and select ambulatory care clinics.
PGY-2 Hematology/Oncology Program Director: Eun Jeong Kim, Pharm.D., MS, BCOP, BCPS
Stanford Health Care
Department of Pharmacy
300 Pasteur Drive, Room H0301
Stanford, CA 94305-5616
The Hematology/Oncology Residency at Stanford Health Care is a PGY-2 specialty training program that offers extensive hematology and oncology experiences at Stanford Comprehensive Cancer Center. Two applicants are accepted per year.
The program is designed to transition PGY-1 residency graduates from general practice to specialized practice focused on the care of patients with oncologic and/or hematologic disorders. Residency graduates will be equipped to participate as integral members of interdisciplinary teams, assuming responsibility for pharmaceutical care.
Throughout the program, the resident will gain practical experience in the management in neoplastic diseases as well as cancer-related and cancer treatment-related disorders. Due to the prominent use of investigational drugs in the treatment of cancer, the resident will also gain the knowledge and skills necessary to practice effectively in clinical research environments. They will be able to manage the preparation, distribution, and disposal of hazardous medications in both inpatient and ambulatory settings. Their experience will also include leadership in formulary decision-making for cancer-related medications.
Groomed for practice leadership, the PGY-2 Hematology/Oncology resident will be able to successfully serve health-care organizations with the clinical and practice skills necessary for effective decision-making in the treatment of oncologic and hematologic disorders.
The goal of the PGY-2 Hematology/Oncology Residency Program is to provide a broad experience-based foundation in hematology/oncology, to develop his/her clinical skills, and to prepare for a comprehensive clinical practice in hematology/oncology.
The Hematology/Oncology Specialty Residency is accredited by the American Society of Health System Pharmacists (ASHP). The program follows the ASHP Residency Learning System (RLS) and its goals and learning objectives are consistent with standards developed by ASHP.
Required Program Activities
Orientation/Training – 1-2 weeks
Inpatient Oncology – 4-6 weeks
Inpatient Hematology – 4-6 weeks
Inpatient Blood and Marrow Transplantation (BMT) – 4-5 weeks
Outpatient Hematology/Oncology/BMT Clinics – 12 weeks and longitudinal
Research Project – longitudinal
Chemotherapy Preparation and Dispensing – longitudinal
* A maximum of one off-site rotation will be permitted.
Specialized Residency Requirement
Complete and present a research project at the Western States Conference and/or HOPA annual meeting.
Participate in teaching activities with PGY-1 residents and pharmacy students
Prepare and present drug monograph for the Pharmacy & Therapeutics Committee
Staff minimum 8-16 hours every 4 weeks
Attend hematology/oncology related committee meetings and teaching sessions
Eun-Jeong Kim, Pharm.D., MS, BCOP received her degree from the University of Florida in 2003. She completed her pharmacy practice residency at Shands Jacksonville/The University of Florida Academic Health Center and PGY-2 oncology pharmacy residency at University of Washington Medical Center. She worked as a clinical oncology pharmacist at Hematology/Oncology Ambulatory Clinic at Kaiser Permanente and Sutter Health for seven years before joining the hematology/oncology specialty area at Stanford Hospital & Clinics.
Alice Chang, Pharm.D. received her degree from the University of Colorado in 1998. She completed an ambulatory care residency at University of Illinois at Chicago and worked at Olive-View UCLA Medical Center for 4 years before joining Stanford Hospital & Clinics in 2003. She is currently practicing as a clinical oncology pharmacist in the outpatient Cancer Center.
Ya-Hwei Cheng, MS, Pharm.D. received her MS in health system management from Union University, NY and pharmacy degree. from University of Florida. She joined Stanford Hospital & Clinics in 1997. She has practiced in medicine, critical care, cardiology, orthopedics, pediatrics, oncology and investigational drug services. She is currently a clinical pharmacist specializing in BMT.
Magdalena Seyer, Pharm.D., BCPS received her degree from the University of California, San Francisco in 2006. She completed a pharmacy practice residency at Stanford Hospital & Clinics. She worked as a clinical pharmacist for 2 years before transitioning into hematology and oncology at Stanford Hospital & Clinics.
Latanya Dean, Pharm.D., BCOP(Assistant Director Hematology/Oncology) received her degree from the University of Washington in 2001. She completed a general practice residency at Stanford Hospital & Clinics in June 2002. After residency she accepted a clinical position at SHC and worked in the Cancer Center as a Clinical Pharmacist, then as a Lead Pharmacist overseeing the inpatient and outpatient oncology pharmacy services.
Rawmina Keshavarzi, Pharm.D., BCOP received her degree from the University of Maryland in 2013. She completed her pharmacy practice residency and PGY-2 oncology pharmacy residency at UC Davis Medical Center. After completing her residency, she came to Stanford Health Care where she now practices as a clinical oncology pharmacist in the outpatient South Bay Cancer Center.
Ann Le, Pharm.D., BCPS received her degree from the University of California, San Francisco in 2009. She completed a pharmacy practice residency at University of California, San Diego. She completed a hematology/oncology residency at Stanford Hospital & Clinics in 2010 currently works as a clinical pharmacist specializing in hematology and oncology.
Samit Patel, Pharm.D., BCOP graduated from the University of Houston in 2007. He completed his pharmacy practice residency at Presbyterian Hospital of Dallas/Texas Tech University Health Science Center. He completed a hematology/oncology residency at Stanford Hospital & Clinics and currently works as a clinical pharmacist in hematology/oncology.
Faye Tsung, Pharm.D. (Supervisor, outpatient hematology/oncology) received her Bachelors in Pharmacy at the University of Toronto in 1989. In 1990, she completed an Industrial Pharmacy Residency at Eli Lilly Canada Inc. In 1994 she received her Doctor of Pharmacy degree at Philadelphia College of Pharmacy and Science. The following year she completed an oncology residency at the University of Illinois at Chicago. She joined Stanford Hospital & Clinics in 2002 and currently works as a Lead Pharmacist overseeing the inpatient and outpatient oncology pharmacy services.
Joanna Wang, Pharm.D. received her undergraduate degree in Biology from the University of California, Irvine and her Doctor of Pharmacy degree from the University of Southern California in 1991. She completed her residency at University of California, Los Angeles in 1992 and currently works as a clinical pharmacist in Bone Marrow Transplant & Oncology.
Abraham Chang, Pharm.D., BCOP graduated from the University of the Pacific in 2012. He completed his PGY-1 pharmacy practice residency in 2014 and PGY-2 hematology/oncology residency at Stanford in 2015. He currently works as a clinical pharmacist in hematology/oncology.
Ellen Wong, Pharm.D., BCOP received her degree from the University of California, San Francisco in 2009. She completed a pharmacy practice residency at University of California, Davis. She worked a hematology/oncology clinical pharmacist at UC Davis Medical Center for 3 years before joining the hematology/oncology specialty area at Stanford Healthcare.
Linh Tran, Pharm.D., BCOP earned her degree from Western University of Health Sciences in 2012. She completed a general pharmacy practice residency at Baptist Memorial Hospital in Memphis, TN in 2013 and a hematology/oncology residency at Stanford Hospital and Clinics in 2014. Currently, she works as a clinical pharmacist specializing in hematology and oncology.
Stephanie Tse, Pharm.D., BCOP received her Pharmacy degree from the University of California, San Diego in 2013. She completed her PGY-1 pharmacy practice residency and PGY-2 hematology/oncology pharmacy residency at the University of Washington Medical Center. She worked at the University of Washington & Seattle Cancer Care Alliance as part of the BMT and hematology/oncology team before joining the hematology/oncology specialty area at Stanford Healthcare.
Kathryn Yee, Pharm.D., BCOP received her Pharmacy degree from the University of Maryland in 2014. She completed her PGY-1 pharmacy practice residency at Johns Hopkins Bayview Medical Center and PGY-2 hematology/oncology pharmacy residency at University of California, San Francisco Medical Center. After completing her residency, she came to Stanford Health Care, and currently works as a clinical pharmacist in the outpatient Cancer Center.
Ted Kim, PharmD(Supervisor, inpatient hematology/oncology) received his Pharmacy degree from the University of Texas in Austin in 2014. He completed his training in hematology/oncology and hematopoietic cellular therapy from the Methodist Hospital in San Antonio, TX. After the completion of his training, he worked under a clinical collaborative practice agreement with the Texas Transplant Institute. In addition to his clinical practice, he worked with other HCA institutions to create multi-institutional standard operating procedures, transplant conditioning algorithms, as well as managing the oncology pharmacy team at Methodist. He joined the Stanford Healthcare BMT pharmacy team in February of 2017.
Walter Domingo, Pharm.D., BCOP received his degree from the University of Hawaii at Hilo College of Pharmacy in 2016. He completed his PGY-1 pharmacy practice residency in 2017 and PGY-2 hematology/oncology residency at Stanford in 2018. He currently works as a BMT clinical pharmacist.
Dorie Wang, PharmD, BCOP received her degree from the University of California, San Francisco in 2016. She continued at UCSF to complete both her PGY1 pharmacy practice residency and PGY2 oncology pharmacy residency. She currently works as a clinical pharmacist in hematology/oncology.
Postgraduate Year Two (PGY-2) Pharmacy Stanford Resident: 2019 – 2020
Nicholas received his Bachelor of Science degree in Biology from San Francisco State University as well as his Doctor of Pharmacy and Master of Public Health degrees from Touro University California. He completed his PGY1 Pharmacy Practice Residency at Stanford Health Care. His professional interests include bone marrow transplantation, hematology, and infectious disease. In his free time, Nick enjoys exercising, traveling, and trying new food and coffee shops.
Compensation & Benefits
PGY-2 residents receive a competitive annual stipend of approximately $84,000 with full benefits, including an excellent health-care benefits package and 10 days paid time off. In addition, the PGY-2 resident will enjoy educational leave and a stipend to attend and participate at various pharmacy conferences throughout the year.
Participation in our Hematology/Oncology Specialty Residency Program requires a Pharm.D. degree from an ACPE-accredited College or School of Pharmacy and completion of an ASHP-accredited PGY-1 residency. Out of state candidates must obtain a California Intern license prior to the first day of residency and California Pharmacist licensure must be obtained within 3 months of start date of residency.
PGY-2 Application Process
Interested applicants must complete ALL of the following:
Under "Search by Req #", enter "47455" and click "Start Job Search".
Follow the instructions on the website.
Under the resume section, please attach your Curriculum Vitae.
When finished, click submit.
For consideration, the online application and all supporting documentation must be received by Tuesday, December 31, 2019. Early submission is helpful.
After all application materials have been reviewed, selected applicants will be contacted for a half-day on-site interview to be conducted in February 2019. The date of the interview is negotiable based on candidate and interview panel schedules. The candidate is required to give a 15 minute Powerpoint presentation on oncology topics.
Interviews will be conducted in February 2020.
The application deadline is Tuesday, December 31, 2019.
NO applications will be accepted beyond this date.